申请人:Hoechst-Roussel Pharmaceuticals Incorporated
公开号:US05350762A1
公开(公告)日:1994-09-27
There are disclosed various compounds of the formula below, ##STR1## where the various parameters R.sub.1, R.sub.2, R.sub.3, R.sub.4, X, m and n are as defined in the specification, which show activities as a monoamine oxidase inhibitor demonstrating a utility for the treatment of depression, and activities as a cholinesterase inhibitor demonstrating a utility for the treatment of various memory dysfunctions such as Alzheimer's disease.
下面公式中披露了各种化合物,##STR1## 其中各种参数 R.sub.1、R.sub.2、R.sub.3、R.sub.4、X、m 和 n 如规范中所定义,这些化合物表现出作为单胺氧化酶抑制剂的活性,显示了用于治疗抑郁症的效用,以及作为胆碱酯酶抑制剂的活性,显示了用于治疗各种记忆功能障碍,如阿尔茨海默病的效用。